Inovio Pharmaceuticals: Q1 Earnings Insights

Inovio Pharmaceuticals INO reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Inovio Pharmaceuticals missed estimated earnings by 14.29%, reporting an EPS of $-0.16 versus an estimate of $-0.14.

Revenue was down $84 thousand from the same period last year.

Last quarter the company missed on EPS by $0.05 which was followed by a 4.84% increase in the share price the next day.

Here's a look at Inovio Pharmaceuticals's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-0.17	-0.30	-0.31	-0.34
EPS Actual	-0.22	-0.15	-0.46	-0.36
Revenue Estimate	340K	620K	520K	670K
Revenue Actual	125K	9.15M	784K	199K

To track all earnings releases for Inovio Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar